Hofseth BioCare in Catalent pact to develop delayed-release fish oil capsules 13-May-2021 By Will Chu Norwegian biotech firm Hofseth BioCare (HBC) are to partner up with drug delivery specialists Catalent in an agreement that looks to develop a delayed-release formulation of HBC’s OmeGo salmon oil.